Published in Osteoporos Int on December 18, 2009
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med (2009) 13.74
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg (2004) 6.38
Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med (2005) 3.57
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther (2002) 2.83
Guidelines on the management of Paget's disease of bone. Bone (2002) 2.34
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol (2007) 2.24
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients. Clin Cancer Res (2007) 2.18
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. J Clin Pharmacol (2002) 2.03
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res (2002) 1.97
Antitumor effects of bisphosphonates. Cancer (2003) 1.66
Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med (2006) 1.65
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res (2003) 1.61
Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J Natl Cancer Inst (2007) 1.56
Bisphosphonates and osteonecrosis of the jaw. Rheumatology (Oxford) (2007) 1.45
Bisphosphonates in cancer therapy. Cancer Lett (2007) 1.36
Alterations in skeletal perfusion with simulated microgravity: a possible mechanism for bone remodeling. J Appl Physiol (1985) (2000) 1.31
Actinomycosis of the jaws--histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch (2007) 1.14
Composition of bone and apatitic biomaterials as revealed by intravital Raman microspectroscopy. Bone (2005) 1.14
Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat. J Bone Miner Res (2008) 1.11
Intraosseous circulation from physiology to disease. Joint Bone Spine (2002) 1.07
Prolonged efficacy of a single dose of the bisphosphonate zoledronic acid. Clin Cancer Res (2007) 1.05
Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res (2007) 1.03
Biology of bone endothelial cells. Bone Miner (1990) 1.02
Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases. Med Oncol (2008) 0.86
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer. Clin Cancer Res (2003) 0.85
Effect of pamidronate on bone blood flow in oophorectomized rats. Physiol Res (1998) 0.82
Vascular density profile of rat mammary carcinomas induced by 1-methyl-1-nitrosourea: implications for the investigation of angiogenesis. Carcinogenesis (2002) 0.81
Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat. Physiol Res (2000) 0.80
A preliminary investigation into the effects of X-ray radiation on superficial cranial vascularization. Calcif Tissue Int (2009) 0.79
Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up. Radiology (1996) 2.90
Percutaneous vertebroplasty: state of the art. Radiographics (1998) 2.29
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis. Br J Surg (2012) 1.84
Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med (1998) 1.25
Lung changes in rheumatoid arthritis: CT findings. Radiology (1994) 1.19
Lack of efficacy of a third tumour necrosis factor alpha antagonist after failure of a soluble receptor and a monoclonal antibody. Rheumatology (Oxford) (2006) 1.17
Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects. Osteoporos Int (2011) 1.12
Peripheral pyogenic arthritis. A study of one hundred seventy-nine cases. Rev Rhum Engl Ed (1996) 1.11
Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab (1998) 1.11
The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int (2009) 1.07
Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF). Curr Med Res Opin (2012) 0.91
Should percutaneous vertebroplasty be used to treat osteoporotic fractures? An update. Joint Bone Spine (2001) 0.89
Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone (2004) 0.88
A clinical tool to determine the necessity of spine radiography in postmenopausal women with osteoporosis presenting with back pain. Ann Rheum Dis (2006) 0.88
Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases. Rev Rhum Engl Ed (1996) 0.87
[Value of a synthetic osseous model obtained by stereo-lithography for preoperative planning. Correction of a complex femoral deformity caused by fibrous dysplasia]. Rev Chir Orthop Reparatrice Appar Mot (1997) 0.87
Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteoporos Int (2010) 0.87
Therapeutic percutaneous injections in the treatment of malignant acetabular osteolyses. Radiographics (1999) 0.87
Fear of falling as seen in the Multidisciplinary falls consultation. Ann Phys Rehabil Med (2011) 0.85
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporos Int (2011) 0.84
Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011. Osteoporos Int (2014) 0.83
["Spontaneous" hematoma of the psoas in Gaucher's disease]. Rev Med Interne (1993) 0.83
Preoperative percutaneous injection of methyl methacrylate and N-butyl cyanoacrylate in vertebral hemangiomas. AJNR Am J Neuroradiol (1996) 0.83
[Giant cell tumors of the spine. Report of a case, literature review]. Acta Orthop Belg (1997) 0.83
Rheumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates. J Rheumatol (2000) 0.82
Contribution of calcaneal ultrasonic assessment to the evaluation of postmenopausal and glucocorticoid-induced osteoporosis. Rev Rhum Engl Ed (1997) 0.81
Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses. Eur Respir J (2011) 0.80
Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. J Neurol (2009) 0.80
Quantitative ultrasound of bone in male osteoporosis. Osteoporos Int (2002) 0.80
Abdominal aortic aneurysm. A rare cause of destructive lesions of the spine. Rev Rhum Engl Ed (1996) 0.80
Six-minute stepper test to assess effort intolerance in interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis (2012) 0.80
Predictive factors of change in BMD at 1 and 2 years in women with anorexia nervosa: a study of 146 cases. Osteoporos Int (2012) 0.79
[Suicide risk and suicide attempt in North Pas de Calais Region. Lessons from the survey Mental Health in General Population]. Encephale (2010) 0.79
Epidemiology of esophageal atresia. Dis Esophagus (2013) 0.79
[Treatment of refractory rheumatoid arthritis with cyclosporine]. Rev Med Interne (1994) 0.79
Movement preparation and cortical processing of afferent inputs in cortical tremor: an event-related (de)synchronization (ERD/ERS) study. Clin Neurophysiol (2011) 0.79
No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site. Bone (2009) 0.78
Dexamethasone eluting electrodes for cochlear implantation: Effect on residual hearing. Cochlear Implants Int (2014) 0.78
[Prevention of glucocorticoid induced osteoporosis]. Rev Med Interne (1998) 0.78
Home telemonitoring (forced expiratory volume in 1 s) in children with severe asthma does not reduce exacerbations. Eur Respir J (2011) 0.77
[Recommendations for the management of bone demineralization in cystic fibrosis]. Arch Pediatr (2008) 0.77
[Osteoporosis in pregnancy: apropos of 2 cases]. Rev Med Interne (1997) 0.77
[Intravascular lymphoma revealed by generalized arborescent telangiectasia and repeated venous thrombosis]. Ann Dermatol Venereol (2008) 0.76
A Comprehensive Fracture Prevention Strategy in Older Adults: The European Union Geriatric Medicine Society (EUGMS) Statement. J Nutr Health Aging (2016) 0.76
Molecular alterations of bone quality in sequesters of bisphosphonates-related osteonecrosis of the jaws. Osteoporos Int (2013) 0.76
Ultrasound velocity through the phalanges in normal and osteoporotic patients. Calcif Tissue Int (1999) 0.76
[Assessment of anxiety, pain and its management in prenatal diagnosis procedures]. J Gynecol Obstet Biol Reprod (Paris) (2011) 0.76
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. Aliment Pharmacol Ther (2011) 0.75
Mathematical coupling of data between global-end diastolic volume index and cardiac index calculated by the PiCCO device: myth or reality? Minerva Anestesiol (2013) 0.75
[What do we think about selective estrogen receptor modulators?]. Rev Med Interne (2001) 0.75
Natural course of erosive arthropathy of the hand in patients undergoing hemodialysis. Skeletal Radiol (1997) 0.75
[Prepatellar acute calcifying periarthritis disclosing Crest syndrome]. Rev Rhum Ed Fr (1993) 0.75
Molecular interaction between bisphosphonates and human bone: a preliminary study on osteonecrosis sequesters of the jaw. Bull Group Int Rech Sci Stomatol Odontol (2011) 0.75
[Observational survey on variations of prostate cancer incidence by stage in the Nord-Pas-de-Calais region between 1998 and 2004]. Prog Urol (2008) 0.75
[Determine the patient's position towards psychiatric care: a simple tool to estimate the alliance and the motivation]. Encephale (2013) 0.75
[Estrogens still and always?]. Rev Med Interne (2000) 0.75
Pooled results from 2 trials evaluating biphosphonates in reflex sympathetic dystrophy. J Rheumatol (1999) 0.75
Self-regulation of exercise intensity by estimated time limit scale. Eur J Appl Physiol (2011) 0.75
[Rheumatoid arthritis and cystic fibrosis]. Rev Mal Respir (2005) 0.75
[Bone health in Geneva retirees]. Rev Med Suisse (2015) 0.75
[Clinical equipoise and randomised clinical trials in oncology]. Bull Cancer (2009) 0.75
Long-term efficacy of percutaneous drill-biopsy under computed tomography guidance of osteoid osteomas of the hip and femur. A review of seven cases. Joint Bone Spine (2000) 0.75
Causes of osteoporosis in males. A review of 160 cases. Rev Rhum Engl Ed (1999) 0.75
Compatibility of fluorochrome labeling protocol with Raman spectroscopy to study bone formation. Bull Group Int Rech Sci Stomatol Odontol (2011) 0.75
[Bone metastases of uterine leiomyosarcoma. Apropos of a case]. Rev Rhum Ed Fr (1994) 0.75
Prediction of macrosomia by serial sonographic measurements of fetal soft-tissues and the liver in women with pregestational diabetes. Diabetes Metab (2013) 0.75